IR release & Materials｜INVESTOR RELATIONS

IR：ALL

2025.02.14 Financial results	Financial Results Presentation with note for Q1 FY2025
2025.02.13 Financial results	Financial Results Presentation for Q1 FY2025
2025.02.12 Timely disclosure	Notice Concerning Succession of Business through Company Split (Simplified Absorption-type Company Split)
2025.02.12 Financial results	Financial Results for Q1 FY2025
2025.01.31 Timely disclosure	Notice Concerning Posting of Extraordinary Income, Income Taxes – Deferred and Revision of First Half and Full Year Consolidated Results Forecasts
2025.01.21 Timely disclosure	Notice Regarding Issuance of New Shares as Restricted Stock Remuneration and Cancellation of Treasury Stock
2025.01.08 Information	Bridge Report: MTI Fiscal Year ended September 2024
2024.12.23 Timely disclosure	Notice of Consolidated Subsidiary (Pharmo Inc.)’s Capital Increase Through Third-Party Allotment of Shares
2024.12.23 Shareholders' meeting	Notice of Results of Voting Rights at the 29th Annual General Meeting of Shareholders
2024.12.23 Timely disclosure	Matters Concerning a Controlling Shareholder, etc.
2024.12.23 Timely disclosure	Notice Concerning Additional Acquisition of Shares in a Consolidated Subsidiary to Make it a Wholly Owned Subsidiary
2024.12.23 Timely disclosure	Notice of Personnel Changes Regarding Officers
2024.12.21 Shareholders' meeting	Reporting Session for Shareholders at the 29th Annual General Meeting
2024.12.05 Timely disclosure	Overview of Evaluation Results on the Effectiveness of our Board of Directors
2024.11.29 Shareholders' meeting	Notice of the 29th Annual General Meeting of Shareholders
2024.11.22 Timely disclosure	Notice of Personnel Changes Regarding Officers
2024.11.20 Information	CEO Message for FY2024
2024.11.19 Financial results	Financial Results Presentation with note for FY2024
2024.11.08 Financial results	Financial Results Presentation for FY2024
2024.11.07 Financial results	Financial Results for FY2024

1 2 … 14 >